Price | 1784€+ Login to see price |
Organism | Human |
Product Type | Organoid |
Tissue | Endometrial cancer |
Disease | Endometrial cancer |
Applications
Oncology
Small Molecule
Antibody
Cancer Vaccine
mRNA
Immune Cell
TME-CAF
Immuno Oncology
Macrophage
Regulatory T Cell
Tumor-Infiltrating Lymphocyte
Cytotoxic T Cell
Utilize our precision-engineered endometrial cancer organoids for effective therapy development and detailed tumor analysis. These organoids replicate patient tumor characteristics, offering a robust model for exploring targeted treatments and hormone dynamics. Transform endometrial cancer research and accelerate discovery with our advanced organoid platform.
We performed immunofluorescence staining on our endometrial cancer organoids to confirm their similarity to patient tissue. The results demonstrated that both pan-cytokeratin (Pan-CK), an epithelial cell marker, and Vimentin (VIM), an endometrial cancer tumor marker, were expressed in a pattern similar to the patient tissue. Additionally, the expression of anti-estrogen receptor (ER-α) and anti-progesterone receptor (PR) in the organoids mirrored that in the patient tissue. These organoids, which faithfully replicate the cellular and molecular characteristics of the primary tumor, offer a powerful platform for developing and testing targeted treatments, studying tumor behavior, and exploring hormone receptor dynamics in endometrial cancer.
H&E | Pan-CK | VIM | ER-a | PR | |
|---|---|---|---|---|---|
Cancer tissue |  |  |  | ||
Cancer organoid |  |  |  | ||
